News Story: Full Text
Sponsored By
Tocagen Clinical Trial
Please Click On The Above Banner For More Details
Braintumor Website


Cancer Exports Molecular ‘Saboteurs’ to Remotely Disarm Immune System


Al Musella's Comments: (This is his personal views and are not necessarily the views of the Musella Foundation!)

 This may be the missing link in understanding how the immune system fights cancer and why checkpoint inhibitors do not allwas work.  Excellent research and I hope someone tests this in brain tumors.


Posted on: 05/09/2019

Cancer Exports Molecular ‘Saboteurs’ to Remotely Disarm Immune System
Immunotherapy drugs known as checkpoint inhibitors have revolutionized cancer treatment: many patients with malignancies that until recently would have been considered untreatable are experiencing long-term remissions. But the majority of patients don’t respond to these drugs, and they work far better in some cancers than others, for reasons that have befuddled scientists. Now, UC San...

Read in Science & Technology Research News: https://apple.news/AxrPfpVRmSkSF4nMJYiakGQ

 




Click HERE to return to brain tumor news headlines


Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740